Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Antihyperlipidemic agents from natural source described by Takeda

Dec. 2, 1996

Potent ACAT inhibitor discovered by Kitasato Institute

Dec. 2, 1996

Lilly research into antiobesity proteins continues

Dec. 2, 1996

Avigen reports successful gene therapy with EPO

Nov. 29, 1996

Harvard Scientific seeks to proceed with clinical trials on erectile dysfunction Rx

Nov. 29, 1996

Animal model for testing osteoporotic therapies available for licensing

Nov. 29, 1996

rhBMP-2 cleared for limited clinical trial for spine fusion

Nov. 28, 1996

FDA clears treatment for bulimia

Nov. 27, 1996

Water-soluble fiber introduced in first market for high cholesterol

Nov. 27, 1996

Agreement reached for atorvastatin development in Japan

Nov. 27, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 7, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 7, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...